0000905718-17-000183.txt : 20170209 0000905718-17-000183.hdr.sgml : 20170209 20170209123644 ACCESSION NUMBER: 0000905718-17-000183 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170209 DATE AS OF CHANGE: 20170209 EFFECTIVENESS DATE: 20170209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHD Bioscience, Inc. CENTRAL INDEX KEY: 0001604801 IRS NUMBER: 841445770 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-279488 FILM NUMBER: 17586452 BUSINESS ADDRESS: STREET 1: 2950 EAST HARMONY STREET 2: SUITE 252 CITY: FORT COLLINS STATE: CO ZIP: 80528 BUSINESS PHONE: 970-295-4373 MAIL ADDRESS: STREET 1: 2950 EAST HARMONY STREET 2: SUITE 252 CITY: FORT COLLINS STATE: CO ZIP: 80528 D/A 1 primary_doc.xml X0707 D/A LIVE 0001604801 CHD Bioscience, Inc. 2950 EAST HARMONY SUITE 252 FORT COLLINS CO COLORADO 80528 970-295-4373 COLORADO None None Corporation true Dennis Templar 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Executive Officer Director Robert Kali 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Executive Officer Roy Carver, Jr. 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Director Stephen Coder 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Director Michael Litwack 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Director Alan Ruud 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Director Loretta Mealy 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Director Ed Neas 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Executive Officer Director Alan Smith 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Director Ted Ziemann 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Executive Officer Director Michael Handley 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Executive Officer Director William Nelson 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Director Other Health Care Decline to Disclose 06b true 0000905718-17-000156 true false true true false 0 CG CAPITAL MARKETS LLC 35513 None None 327 PLAZA REAL SUITE 225 BOCA RATON FL FLORIDA 33432 AL ALABAMA AK ALASKA AZ ARIZONA AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA HI HAWAII ID IDAHO IL ILLINOIS IN INDIANA IA IOWA KS KANSAS KY KENTUCKY LA LOUISIANA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI MT MONTANA NE NEBRASKA NH NEW HAMPSHIRE NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA ND NORTH DAKOTA OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA SD SOUTH DAKOTA TN TENNESSEE TX TEXAS UT UTAH VT VERMONT VA VIRGINIA WA WASHINGTON WV WEST VIRGINIA WI WISCONSIN WY WYOMING PR PUERTO RICO false 14000000 0 14000000 false 0 840000 true 0 Assumes maximum commissions earned by one or more non-exclusive agents or sub agents as more fully set forth in the offering materials. Excludes warrants to purchase up to 1,272,727 shares. 0 true Some of the procedes may be used for general working capital purposes including the payment of salaries and other fees to those listed in Item 3. false CHD Bioscience, Inc. /s/ Robert Kali Robert Kali Chief Financial Officer 2017-02-09